Correlation Between Xintela AB and Alligator Bioscience
Can any of the company-specific risk be diversified away by investing in both Xintela AB and Alligator Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xintela AB and Alligator Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xintela AB and Alligator Bioscience AB, you can compare the effects of market volatilities on Xintela AB and Alligator Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xintela AB with a short position of Alligator Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xintela AB and Alligator Bioscience.
Diversification Opportunities for Xintela AB and Alligator Bioscience
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Xintela and Alligator is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Xintela AB and Alligator Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alligator Bioscience and Xintela AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xintela AB are associated (or correlated) with Alligator Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alligator Bioscience has no effect on the direction of Xintela AB i.e., Xintela AB and Alligator Bioscience go up and down completely randomly.
Pair Corralation between Xintela AB and Alligator Bioscience
Assuming the 90 days trading horizon Xintela AB is expected to generate 0.74 times more return on investment than Alligator Bioscience. However, Xintela AB is 1.35 times less risky than Alligator Bioscience. It trades about 0.01 of its potential returns per unit of risk. Alligator Bioscience AB is currently generating about -0.03 per unit of risk. If you would invest 47.00 in Xintela AB on September 24, 2024 and sell it today you would lose (14.00) from holding Xintela AB or give up 29.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Xintela AB vs. Alligator Bioscience AB
Performance |
Timeline |
Xintela AB |
Alligator Bioscience |
Xintela AB and Alligator Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Xintela AB and Alligator Bioscience
The main advantage of trading using opposite Xintela AB and Alligator Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xintela AB position performs unexpectedly, Alligator Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alligator Bioscience will offset losses from the drop in Alligator Bioscience's long position.Xintela AB vs. BioInvent International AB | Xintela AB vs. Alligator Bioscience AB | Xintela AB vs. Moberg Pharma AB | Xintela AB vs. Oncopeptides AB |
Alligator Bioscience vs. BioInvent International AB | Alligator Bioscience vs. Orexo AB | Alligator Bioscience vs. Swedish Orphan Biovitrum | Alligator Bioscience vs. Anoto Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |